Denis Chem Lab Falls 5.51%: Financial Decline and 52-Week Low Mark a Challenging Week
2026-11-08 09:00:08Key Events This Week 2 Nov: Stock opens strong at Rs.62.90 (+2.78%) 3 Nov: Mild correction to Rs.62.06 (-1.34%) 4 Nov: Sharp decline to Rs.60.01 (-3.30%) 5 Nov: Hits 52-week low at Rs.55.50 amid financial woes 6 Nov: Slight recovery to Rs.57.83 (+1.94%) Week OpenRs.61.20 Week Clos...
Read More
Denis Chem Lab Ltd Reports Sharp Financial Decline in Q3 2026 Amid Sector Challenges
2026-11-05 08:00:21Denis Chem Lab Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has reported a significant deterioration in its financial performance for the quarter ended September 2026. The company’s recent quarterly results reveal a stark reversal from previous trends, with revenue, profitability, and cash flow metrics all registering notable declines, further compounded by a steep drop in its stock price and a downgrade in its Mojo Grade to Strong Sell.
Read More
Denis Chem Lab Ltd is Rated Strong Sell
2026-11-01 10:10:46Denis Chem Lab Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 08 October 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 November 2026, providing investors with the most up-to-date view of the company's fundamentals, returns, and technical outlook.
Read More
Denis Chem Lab Ltd Downgraded to Strong Sell Amid Weak Technicals and Financial Trends
2026-10-09 08:03:42Denis Chem Lab Ltd has been downgraded from a Sell to a Strong Sell rating following a comprehensive reassessment of its quality, valuation, financial trend, and technical indicators. The downgrade reflects deteriorating technical signals, flat recent financial performance, and underwhelming long-term returns, despite some attractive valuation metrics.
Read More
Denis Chem Lab Ltd Upgraded to Sell on Technical Improvements Despite Flat Financials
2026-10-02 08:07:12Denis Chem Lab Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Strong Sell to Sell as of 1 October 2026. This change reflects a nuanced shift in the company’s technical outlook despite persistent challenges in its financial and quality metrics. The upgrade is primarily driven by improvements in technical indicators, while valuation and financial trends continue to weigh on investor sentiment.
Read More
Denis Chem Lab Ltd is Rated Strong Sell
2026-09-28 10:10:54Denis Chem Lab Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 15 September 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 September 2026, providing investors with the most up-to-date perspective on the company’s performance and outlook.
Read MoreDenis Chem Lab Ltd Falls 7.92%: Downgrade and Valuation Shift Shape the Week
2026-09-20 09:00:05Key Events This Week 15 Sep: Stock opens at ₹71.44, closes at ₹70.46 (-1.37%) amid downgrade announcement 16 Sep: Downgrade to Strong Sell confirmed; valuation grade improves to Attractive 17 Sep: Continued price decline to ₹68.29 (-2.67%) on rising volume 18 Sep: Week closes at ₹65.78 (-3.68%) despite Sensex gains Week OpenRs.71.44 <div class="st...
Read More
Denis Chem Lab Ltd Downgraded to Strong Sell Amid Mixed Valuation and Weak Financial Trends
2026-09-16 08:05:50Denis Chem Lab Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 15 Sep 2026. Despite an upgrade in its valuation grade from very attractive to attractive, the company’s overall financial and technical outlook has deteriorated, prompting a cautious stance among investors.
Read More
Denis Chem Lab Ltd Valuation Shifts Signal Changing Market Perception
2026-09-16 08:00:27Denis Chem Lab Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation parameters improve notably, shifting from very attractive to attractive. Despite a recent downgrade to a Strong Sell rating, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a more compelling entry point relative to peers and historical averages, warranting a closer examination by investors navigating a challenging market environment.
Read MoreRevised Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
13-Nov-2026 | Source : BSEThe Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for VS Holding BV
Announcement under Regulation 30 (LODR)-Newspaper Publication
05-Nov-2026 | Source : BSEFind Attach Newspaper Publication
Board Meeting Outcome for Outcome For Board Meeting - Submission Of Un-Audited Financial Results For The Quarter Ended On 30Th September 2026.
04-Nov-2026 | Source : BSEThe Board of Directors in their meeting held today have taken on record the Un-audited Financial Results for the Quarter ended on 30th September 2026.
Corporate Actions
No Upcoming Board Meetings
Denis Chem Lab Ltd has declared 25% dividend, ex-date: 18 Sep 26
No Splits history available
No Bonus history available
Denis Chem Lab Ltd has announced 2:11 rights issue, ex-date: 07 Sep 17